Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvant immunotherapy.

J E Goodnight, D L Morton

    International Advances in Surgical Oncology
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Immunotherapy shows promise for controlling cancer micrometastases when used alongside traditional treatments. Stimulating the body's immune system may help eliminate remaining cancer cells after primary tumor removal.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer.

    Seminars in oncology·2001
    Same author

    Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma.

    CA: a cancer journal for clinicians·2001
    Same author

    Immunology of gangliosides.

    Indian journal of experimental biology·2001
    Same author

    Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2000

    Area of Science:

    • Oncology
    • Immunology
    • Cancer Therapeutics

    Background:

    • Systemic spread of cancer (micrometastases) is common and can lead to treatment failure.
    • Current treatments like surgery, radiation, and chemotherapy have limitations in eradicating all cancer cells.
    • A need exists for agents that selectively target and eliminate minimal residual disease without increasing toxicity.

    Purpose of the Study:

    • To explore the potential of immunotherapy as an integral part of cancer treatment.
    • To investigate immunotherapy's role in controlling occult micrometastases.
    • To assess immunotherapy as an adjuvant to standard cancer therapies.

    Main Methods:

    • Review of experimental observations and clinical testing of immunotherapy.
    • Evaluation of immunotherapy's efficacy when combined with surgery, radiation therapy, and chemotherapy.

    Related Experiment Videos

  • Analysis of evidence for immunotherapy's impact on host resistance against cancer.

    • Main Results:

    • Immunotherapy has demonstrated benefits for selected cancer patients when used adjunctively.
    • Stimulation of host resistance through immunotherapy can lead to control of systemic micrometastases.
    • Initial investigations suggest immunotherapy's potential in comprehensive cancer treatment.

    Conclusions:

    • Adjuvant immunotherapy holds promise for improving cancer treatment outcomes.
    • Further research is needed to fully understand mechanisms and optimize practical applications of immunotherapy.
    • Immunotherapy may play a vital role in eradicating residual cancer cells and preventing recurrence.